Journal
JOURNAL OF NEUROTRAUMA
Volume 39, Issue 21-22, Pages 1524-1532Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/neu.2022.0113
Keywords
clinical trials; post-concussion symptoms; prognosis; risk factors; sample enrichment; TBI
Funding
- National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [UO1-NS086090]
- Department of Defense (DoD) [W81XWH-14-2-0176]
- NINDS [R01 NS110856]
Ask authors/readers for more resources
Factors such as TBI-related and post-traumatic stress symptom levels at 2 weeks have large effect sizes when predicting 3-month symptom burden, allowing for more efficient clinical trials by enriching the included sample with individuals reporting a high early symptom burden.
More than 75% of patients presenting to level I trauma centers in the United States with suspicion of TBI sufficient to require a clinical computed tomography scan report injury-related symptoms 3 months later. There are currently no approved treatments, and few clinical trials have evaluated possible treatments. Efficient trials will require subject inclusion and exclusion criteria that balance cost-effective recruitment with enrolling individuals with a higher chance of benefiting from the interventions. Using data from the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study, we examined the relationship of 3-month symptoms to pre-injury, demographic, and acute characteristics as well as 2-week symptoms and blood-based biomarkers to identify and evaluate factors that may be used for sample enrichment for clinical trials. Many of the risk factors for TBI symptoms reported in the literature were supported, but the effect sizes of each were small or moderate (< 0.5). The only factors with large effect sizes when predicting 3-month symptom burden were TBI-related (i.e., post-concussive) and post-traumatic stress symptom levels at 2 weeks (respective effect sizes 1.13 and 1.34). TBI severity was not significantly associated with 3-month symptom burden (p = 0.37). Using simulated data to evaluate the effect of enrichment, we showed that including only people with high symptom burden at 2 weeks would permit trials to reduce the sample size by half, with minimal increase in screening, as compared with enrolling an unenriched sample. Clinical trials aimed at reducing symptoms after TBI can be efficiently conducted by enriching the included sample with people reporting a high early symptom burden.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available